In this article we will discuss Durvalumab (Patient Counseling-1). So, let’s get started.
One has to inform patients the risk of immune-mediated adverse reactions with Durvalumab that may require corticosteroid treatment and interruption or discontinuation of Durvalumab.
• Pneumonitis: Advise patients to contact their healthcare provider immediately for any new or worsening cough, chest pain, or shortness of breath.